Global Inactivated Polio and Rabies Vaccines Supply, Demand and Key Producers, 2023-2029

Page: 100

Published Date: 23 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Inactivated Polio and Rabies Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. Rabies virus is transferred to humans through the saliva of an animal who is infected by it. Inactivated rabies virus (IRV) is injected before or after the infection of the virus in 1 ml doses having 2.5 IU per ml of rabies virus antigen.

This report studies the global Inactivated Polio and Rabies Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Inactivated Polio and Rabies Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Polio and Rabies Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Inactivated Polio and Rabies Vaccines total production and demand, 2018-2029, (K Dose)
Global Inactivated Polio and Rabies Vaccines total production value, 2018-2029, (USD Million)
Global Inactivated Polio and Rabies Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Inactivated Polio and Rabies Vaccines consumption by region & country, CAGR, 2018-2029 & (K Dose)
U.S. VS China: Inactivated Polio and Rabies Vaccines domestic production, consumption, key domestic manufacturers and share
Global Inactivated Polio and Rabies Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Dose)
Global Inactivated Polio and Rabies Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Inactivated Polio and Rabies Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
This reports profiles key players in the global Inactivated Polio and Rabies Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, BIO-MED, Serum Institute of India, Kedrion Biopharma, GlaxoSmithKline, Merck and Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Polio and Rabies Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Inactivated Polio and Rabies Vaccines Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Inactivated Polio and Rabies Vaccines Market, Segmentation by Type
    Inactivated Polio Vaccine
    Inactivated Rabies Vaccine

Global Inactivated Polio and Rabies Vaccines Market, Segmentation by Application
    Pediatrics
    Adults

Companies Profiled:
    Bharat Biotech
    BIO-MED
    Serum Institute of India
    Kedrion Biopharma
    GlaxoSmithKline
    Merck
    Pfizer

Key Questions Answered
1. How big is the global Inactivated Polio and Rabies Vaccines market?
2. What is the demand of the global Inactivated Polio and Rabies Vaccines market?
3. What is the year over year growth of the global Inactivated Polio and Rabies Vaccines market?
4. What is the production and production value of the global Inactivated Polio and Rabies Vaccines market?
5. Who are the key producers in the global Inactivated Polio and Rabies Vaccines market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Inactivated Polio and Rabies Vaccines Introduction
    1.2 World Inactivated Polio and Rabies Vaccines Supply & Forecast
        1.2.1 World Inactivated Polio and Rabies Vaccines Production Value (2018 & 2022 & 2029)
        1.2.2 World Inactivated Polio and Rabies Vaccines Production (2018-2029)
        1.2.3 World Inactivated Polio and Rabies Vaccines Pricing Trends (2018-2029)
    1.3 World Inactivated Polio and Rabies Vaccines Production by Region (Based on Production Site)
        1.3.1 World Inactivated Polio and Rabies Vaccines Production Value by Region (2018-2029)
        1.3.2 World Inactivated Polio and Rabies Vaccines Production by Region (2018-2029)
        1.3.3 World Inactivated Polio and Rabies Vaccines Average Price by Region (2018-2029)
        1.3.4 North America Inactivated Polio and Rabies Vaccines Production (2018-2029)
        1.3.5 Europe Inactivated Polio and Rabies Vaccines Production (2018-2029)
        1.3.6 China Inactivated Polio and Rabies Vaccines Production (2018-2029)
        1.3.7 Japan Inactivated Polio and Rabies Vaccines Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Inactivated Polio and Rabies Vaccines Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Inactivated Polio and Rabies Vaccines Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Inactivated Polio and Rabies Vaccines Demand (2018-2029)
    2.2 World Inactivated Polio and Rabies Vaccines Consumption by Region
        2.2.1 World Inactivated Polio and Rabies Vaccines Consumption by Region (2018-2023)
        2.2.2 World Inactivated Polio and Rabies Vaccines Consumption Forecast by Region (2024-2029)
    2.3 United States Inactivated Polio and Rabies Vaccines Consumption (2018-2029)
    2.4 China Inactivated Polio and Rabies Vaccines Consumption (2018-2029)
    2.5 Europe Inactivated Polio and Rabies Vaccines Consumption (2018-2029)
    2.6 Japan Inactivated Polio and Rabies Vaccines Consumption (2018-2029)
    2.7 South Korea Inactivated Polio and Rabies Vaccines Consumption (2018-2029)
    2.8 ASEAN Inactivated Polio and Rabies Vaccines Consumption (2018-2029)
    2.9 India Inactivated Polio and Rabies Vaccines Consumption (2018-2029)

3 World Inactivated Polio and Rabies Vaccines Manufacturers Competitive Analysis
    3.1 World Inactivated Polio and Rabies Vaccines Production Value by Manufacturer (2018-2023)
    3.2 World Inactivated Polio and Rabies Vaccines Production by Manufacturer (2018-2023)
    3.3 World Inactivated Polio and Rabies Vaccines Average Price by Manufacturer (2018-2023)
    3.4 Inactivated Polio and Rabies Vaccines Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Inactivated Polio and Rabies Vaccines Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Inactivated Polio and Rabies Vaccines in 2022
        3.5.3 Global Concentration Ratios (CR8) for Inactivated Polio and Rabies Vaccines in 2022
    3.6 Inactivated Polio and Rabies Vaccines Market: Overall Company Footprint Analysis
        3.6.1 Inactivated Polio and Rabies Vaccines Market: Region Footprint
        3.6.2 Inactivated Polio and Rabies Vaccines Market: Company Product Type Footprint
        3.6.3 Inactivated Polio and Rabies Vaccines Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Inactivated Polio and Rabies Vaccines Production Value Comparison
        4.1.1 United States VS China: Inactivated Polio and Rabies Vaccines Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Inactivated Polio and Rabies Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Inactivated Polio and Rabies Vaccines Production Comparison
        4.2.1 United States VS China: Inactivated Polio and Rabies Vaccines Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Inactivated Polio and Rabies Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Inactivated Polio and Rabies Vaccines Consumption Comparison
        4.3.1 United States VS China: Inactivated Polio and Rabies Vaccines Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Inactivated Polio and Rabies Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Inactivated Polio and Rabies Vaccines Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Inactivated Polio and Rabies Vaccines Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Inactivated Polio and Rabies Vaccines Production (2018-2023)
    4.5 China Based Inactivated Polio and Rabies Vaccines Manufacturers and Market Share
        4.5.1 China Based Inactivated Polio and Rabies Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value (2018-2023)
        4.5.3 China Based Manufacturers Inactivated Polio and Rabies Vaccines Production (2018-2023)
    4.6 Rest of World Based Inactivated Polio and Rabies Vaccines Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Inactivated Polio and Rabies Vaccines Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Inactivated Polio and Rabies Vaccines Production (2018-2023)

5 Market Analysis by Type
    5.1 World Inactivated Polio and Rabies Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Inactivated Polio Vaccine
        5.2.2 Inactivated Rabies Vaccine
    5.3 Market Segment by Type
        5.3.1 World Inactivated Polio and Rabies Vaccines Production by Type (2018-2029)
        5.3.2 World Inactivated Polio and Rabies Vaccines Production Value by Type (2018-2029)
        5.3.3 World Inactivated Polio and Rabies Vaccines Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Inactivated Polio and Rabies Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pediatrics
        6.2.2 Adults
    6.3 Market Segment by Application
        6.3.1 World Inactivated Polio and Rabies Vaccines Production by Application (2018-2029)
        6.3.2 World Inactivated Polio and Rabies Vaccines Production Value by Application (2018-2029)
        6.3.3 World Inactivated Polio and Rabies Vaccines Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Bharat Biotech
        7.1.1 Bharat Biotech Details
        7.1.2 Bharat Biotech Major Business
        7.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Product and Services
        7.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Bharat Biotech Recent Developments/Updates
        7.1.6 Bharat Biotech Competitive Strengths & Weaknesses
    7.2 BIO-MED
        7.2.1 BIO-MED Details
        7.2.2 BIO-MED Major Business
        7.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Product and Services
        7.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 BIO-MED Recent Developments/Updates
        7.2.6 BIO-MED Competitive Strengths & Weaknesses
    7.3 Serum Institute of India
        7.3.1 Serum Institute of India Details
        7.3.2 Serum Institute of India Major Business
        7.3.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Product and Services
        7.3.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Serum Institute of India Recent Developments/Updates
        7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
    7.4 Kedrion Biopharma
        7.4.1 Kedrion Biopharma Details
        7.4.2 Kedrion Biopharma Major Business
        7.4.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product and Services
        7.4.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Kedrion Biopharma Recent Developments/Updates
        7.4.6 Kedrion Biopharma Competitive Strengths & Weaknesses
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Details
        7.5.2 GlaxoSmithKline Major Business
        7.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product and Services
        7.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 GlaxoSmithKline Recent Developments/Updates
        7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.6 Merck
        7.6.1 Merck Details
        7.6.2 Merck Major Business
        7.6.3 Merck Inactivated Polio and Rabies Vaccines Product and Services
        7.6.4 Merck Inactivated Polio and Rabies Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Merck Recent Developments/Updates
        7.6.6 Merck Competitive Strengths & Weaknesses
    7.7 Pfizer
        7.7.1 Pfizer Details
        7.7.2 Pfizer Major Business
        7.7.3 Pfizer Inactivated Polio and Rabies Vaccines Product and Services
        7.7.4 Pfizer Inactivated Polio and Rabies Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Pfizer Recent Developments/Updates
        7.7.6 Pfizer Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Inactivated Polio and Rabies Vaccines Industry Chain
    8.2 Inactivated Polio and Rabies Vaccines Upstream Analysis
        8.2.1 Inactivated Polio and Rabies Vaccines Core Raw Materials
        8.2.2 Main Manufacturers of Inactivated Polio and Rabies Vaccines Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Inactivated Polio and Rabies Vaccines Production Mode
    8.6 Inactivated Polio and Rabies Vaccines Procurement Model
    8.7 Inactivated Polio and Rabies Vaccines Industry Sales Model and Sales Channels
        8.7.1 Inactivated Polio and Rabies Vaccines Sales Model
        8.7.2 Inactivated Polio and Rabies Vaccines Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Inactivated Polio and Rabies Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Inactivated Polio and Rabies Vaccines Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Inactivated Polio and Rabies Vaccines Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Inactivated Polio and Rabies Vaccines Production Value Market Share by Region (2018-2023)
    Table 5. World Inactivated Polio and Rabies Vaccines Production Value Market Share by Region (2024-2029)
    Table 6. World Inactivated Polio and Rabies Vaccines Production by Region (2018-2023) & (K Dose)
    Table 7. World Inactivated Polio and Rabies Vaccines Production by Region (2024-2029) & (K Dose)
    Table 8. World Inactivated Polio and Rabies Vaccines Production Market Share by Region (2018-2023)
    Table 9. World Inactivated Polio and Rabies Vaccines Production Market Share by Region (2024-2029)
    Table 10. World Inactivated Polio and Rabies Vaccines Average Price by Region (2018-2023) & (US$/Dose)
    Table 11. World Inactivated Polio and Rabies Vaccines Average Price by Region (2024-2029) & (US$/Dose)
    Table 12. Inactivated Polio and Rabies Vaccines Major Market Trends
    Table 13. World Inactivated Polio and Rabies Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Dose)
    Table 14. World Inactivated Polio and Rabies Vaccines Consumption by Region (2018-2023) & (K Dose)
    Table 15. World Inactivated Polio and Rabies Vaccines Consumption Forecast by Region (2024-2029) & (K Dose)
    Table 16. World Inactivated Polio and Rabies Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Inactivated Polio and Rabies Vaccines Producers in 2022
    Table 18. World Inactivated Polio and Rabies Vaccines Production by Manufacturer (2018-2023) & (K Dose)
    Table 19. Production Market Share of Key Inactivated Polio and Rabies Vaccines Producers in 2022
    Table 20. World Inactivated Polio and Rabies Vaccines Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 21. Global Inactivated Polio and Rabies Vaccines Company Evaluation Quadrant
    Table 22. World Inactivated Polio and Rabies Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Inactivated Polio and Rabies Vaccines Production Site of Key Manufacturer
    Table 24. Inactivated Polio and Rabies Vaccines Market: Company Product Type Footprint
    Table 25. Inactivated Polio and Rabies Vaccines Market: Company Product Application Footprint
    Table 26. Inactivated Polio and Rabies Vaccines Competitive Factors
    Table 27. Inactivated Polio and Rabies Vaccines New Entrant and Capacity Expansion Plans
    Table 28. Inactivated Polio and Rabies Vaccines Mergers & Acquisitions Activity
    Table 29. United States VS China Inactivated Polio and Rabies Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Inactivated Polio and Rabies Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 31. United States VS China Inactivated Polio and Rabies Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 32. United States Based Inactivated Polio and Rabies Vaccines Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Inactivated Polio and Rabies Vaccines Production (2018-2023) & (K Dose)
    Table 36. United States Based Manufacturers Inactivated Polio and Rabies Vaccines Production Market Share (2018-2023)
    Table 37. China Based Inactivated Polio and Rabies Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Inactivated Polio and Rabies Vaccines Production (2018-2023) & (K Dose)
    Table 41. China Based Manufacturers Inactivated Polio and Rabies Vaccines Production Market Share (2018-2023)
    Table 42. Rest of World Based Inactivated Polio and Rabies Vaccines Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Inactivated Polio and Rabies Vaccines Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Inactivated Polio and Rabies Vaccines Production (2018-2023) & (K Dose)
    Table 46. Rest of World Based Manufacturers Inactivated Polio and Rabies Vaccines Production Market Share (2018-2023)
    Table 47. World Inactivated Polio and Rabies Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Inactivated Polio and Rabies Vaccines Production by Type (2018-2023) & (K Dose)
    Table 49. World Inactivated Polio and Rabies Vaccines Production by Type (2024-2029) & (K Dose)
    Table 50. World Inactivated Polio and Rabies Vaccines Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Inactivated Polio and Rabies Vaccines Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Inactivated Polio and Rabies Vaccines Average Price by Type (2018-2023) & (US$/Dose)
    Table 53. World Inactivated Polio and Rabies Vaccines Average Price by Type (2024-2029) & (US$/Dose)
    Table 54. World Inactivated Polio and Rabies Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Inactivated Polio and Rabies Vaccines Production by Application (2018-2023) & (K Dose)
    Table 56. World Inactivated Polio and Rabies Vaccines Production by Application (2024-2029) & (K Dose)
    Table 57. World Inactivated Polio and Rabies Vaccines Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Inactivated Polio and Rabies Vaccines Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Inactivated Polio and Rabies Vaccines Average Price by Application (2018-2023) & (US$/Dose)
    Table 60. World Inactivated Polio and Rabies Vaccines Average Price by Application (2024-2029) & (US$/Dose)
    Table 61. Bharat Biotech Basic Information, Manufacturing Base and Competitors
    Table 62. Bharat Biotech Major Business
    Table 63. Bharat Biotech Inactivated Polio and Rabies Vaccines Product and Services
    Table 64. Bharat Biotech Inactivated Polio and Rabies Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Bharat Biotech Recent Developments/Updates
    Table 66. Bharat Biotech Competitive Strengths & Weaknesses
    Table 67. BIO-MED Basic Information, Manufacturing Base and Competitors
    Table 68. BIO-MED Major Business
    Table 69. BIO-MED Inactivated Polio and Rabies Vaccines Product and Services
    Table 70. BIO-MED Inactivated Polio and Rabies Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. BIO-MED Recent Developments/Updates
    Table 72. BIO-MED Competitive Strengths & Weaknesses
    Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
    Table 74. Serum Institute of India Major Business
    Table 75. Serum Institute of India Inactivated Polio and Rabies Vaccines Product and Services
    Table 76. Serum Institute of India Inactivated Polio and Rabies Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Serum Institute of India Recent Developments/Updates
    Table 78. Serum Institute of India Competitive Strengths & Weaknesses
    Table 79. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
    Table 80. Kedrion Biopharma Major Business
    Table 81. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product and Services
    Table 82. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Kedrion Biopharma Recent Developments/Updates
    Table 84. Kedrion Biopharma Competitive Strengths & Weaknesses
    Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 86. GlaxoSmithKline Major Business
    Table 87. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product and Services
    Table 88. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. GlaxoSmithKline Recent Developments/Updates
    Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 91. Merck Basic Information, Manufacturing Base and Competitors
    Table 92. Merck Major Business
    Table 93. Merck Inactivated Polio and Rabies Vaccines Product and Services
    Table 94. Merck Inactivated Polio and Rabies Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Merck Recent Developments/Updates
    Table 96. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 97. Pfizer Major Business
    Table 98. Pfizer Inactivated Polio and Rabies Vaccines Product and Services
    Table 99. Pfizer Inactivated Polio and Rabies Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 100. Global Key Players of Inactivated Polio and Rabies Vaccines Upstream (Raw Materials)
    Table 101. Inactivated Polio and Rabies Vaccines Typical Customers
    Table 102. Inactivated Polio and Rabies Vaccines Typical Distributors
List of Figure
    Figure 1. Inactivated Polio and Rabies Vaccines Picture
    Figure 2. World Inactivated Polio and Rabies Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Inactivated Polio and Rabies Vaccines Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Inactivated Polio and Rabies Vaccines Production (2018-2029) & (K Dose)
    Figure 5. World Inactivated Polio and Rabies Vaccines Average Price (2018-2029) & (US$/Dose)
    Figure 6. World Inactivated Polio and Rabies Vaccines Production Value Market Share by Region (2018-2029)
    Figure 7. World Inactivated Polio and Rabies Vaccines Production Market Share by Region (2018-2029)
    Figure 8. North America Inactivated Polio and Rabies Vaccines Production (2018-2029) & (K Dose)
    Figure 9. Europe Inactivated Polio and Rabies Vaccines Production (2018-2029) & (K Dose)
    Figure 10. China Inactivated Polio and Rabies Vaccines Production (2018-2029) & (K Dose)
    Figure 11. Japan Inactivated Polio and Rabies Vaccines Production (2018-2029) & (K Dose)
    Figure 12. Inactivated Polio and Rabies Vaccines Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 15. World Inactivated Polio and Rabies Vaccines Consumption Market Share by Region (2018-2029)
    Figure 16. United States Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 17. China Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 18. Europe Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 19. Japan Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 20. South Korea Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 21. ASEAN Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 22. India Inactivated Polio and Rabies Vaccines Consumption (2018-2029) & (K Dose)
    Figure 23. Producer Shipments of Inactivated Polio and Rabies Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Polio and Rabies Vaccines Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Polio and Rabies Vaccines Markets in 2022
    Figure 26. United States VS China: Inactivated Polio and Rabies Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Inactivated Polio and Rabies Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Inactivated Polio and Rabies Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Inactivated Polio and Rabies Vaccines Production Market Share 2022
    Figure 30. China Based Manufacturers Inactivated Polio and Rabies Vaccines Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Inactivated Polio and Rabies Vaccines Production Market Share 2022
    Figure 32. World Inactivated Polio and Rabies Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Inactivated Polio and Rabies Vaccines Production Value Market Share by Type in 2022
    Figure 34. Inactivated Polio Vaccine
    Figure 35. Inactivated Rabies Vaccine
    Figure 36. World Inactivated Polio and Rabies Vaccines Production Market Share by Type (2018-2029)
    Figure 37. World Inactivated Polio and Rabies Vaccines Production Value Market Share by Type (2018-2029)
    Figure 38. World Inactivated Polio and Rabies Vaccines Average Price by Type (2018-2029) & (US$/Dose)
    Figure 39. World Inactivated Polio and Rabies Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Inactivated Polio and Rabies Vaccines Production Value Market Share by Application in 2022
    Figure 41. Pediatrics
    Figure 42. Adults
    Figure 43. World Inactivated Polio and Rabies Vaccines Production Market Share by Application (2018-2029)
    Figure 44. World Inactivated Polio and Rabies Vaccines Production Value Market Share by Application (2018-2029)
    Figure 45. World Inactivated Polio and Rabies Vaccines Average Price by Application (2018-2029) & (US$/Dose)
    Figure 46. Inactivated Polio and Rabies Vaccines Industry Chain
    Figure 47. Inactivated Polio and Rabies Vaccines Procurement Model
    Figure 48. Inactivated Polio and Rabies Vaccines Sales Model
    Figure 49. Inactivated Polio and Rabies Vaccines Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bharat Biotech
BIO-MED
Serum Institute of India
Kedrion Biopharma
GlaxoSmithKline
Merck
Pfizer

Related Reports

Global Inactivated Polio and Rabies Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Inactivated Polio and Rabies Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. Rabies virus is transferred to humans through the saliva of an animal who is infected by it. Inactivated rabies virus (IRV) is injected before or after the infection of the virus in 1 ml doses having 2.5 IU per ml of rabies virus antigen.

Global Inactivated Polio and Rabies Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Inactivated Polio and Rabies Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Inactivated Polio and Rabies Vaccines market size was valued at USD 653.4 million in 2023 and is forecast to a readjusted size of USD 1061.4 million by 2030 with a CAGR of 7.2% during review period.

Global Inactivated Polio and Rabies Vaccines Supply, Demand and Key Producers, 2024-2030

Global Inactivated Polio and Rabies Vaccines Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Inactivated Polio and Rabies Vaccines market size is expected to reach $ 1061.4 million by 2030, rising at a market growth of 7.2% CAGR during the forecast period (2024-2030).

Product Tags

Inactivated Polio and Rabies Vaccines

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>